Treatment of inherited eye defects by systemic hematopoietic stem cell transplantation

Investigative Ophthalmology and Visual Science

Volumn 56, Issue 12, 2015, Pages 7214-7223

  Rocca, Celine J ^a   Kreymerman, Alexander ^b   Ur, Sarah N ^a   Frizzi, Katie E ^c   Naphade, Swati ^a   Lau, Athena ^a   Tran, Tammy ^b   Calcutt, Nigel A ^c   Goldberg, Jeffrey L ^b,d   Cherqui, Stephanie ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d STANFORD UNIVERSITY   (United States)

Author keywords

Corneal cystine crystals; Cystinosis; Hematopoietic stem cell; Tunneling nanotubes

Indexed keywords

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BONE MARROW CELL; CONFOCAL MICROSCOPY; CONTROLLED STUDY; CORNEA DISEASE; CORNEA THICKNESS; CYSTINOSIS; FLUORESCENCE MICROSCOPY; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HISTOLOGY; INTRAOCULAR PRESSURE; MACROPHAGE; MASS SPECTROMETRY; MOUSE; NONHUMAN; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; ANIMAL; C57BL MOUSE; CELL CULTURE; DISEASE MODEL; EYE DISEASES; GENETICS; PROCEDURES; TRANSGENIC MOUSE;

ANIMALS; CELLS, CULTURED; CYSTINOSIS; DISEASE MODELS, ANIMAL; EYE DISEASES; HEMATOPOIETIC STEM CELL TRANSPLANTATION; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC;

EID: 84946542680     PISSN: 01460404     EISSN: 15525783     Source Type: Journal    
DOI: 10.1167/iovs.15-17107     Document Type: Article

References (47)

1. Oliva MS, Schottman T, Gulati M. Turning the tide of corneal blindness. Indian J Ophthalmol. 2012;60:423–427.
2. Haddadin RI, Chodosh J. Corneal transplantation and glaucoma. Semin Ophthalmol. 2014;29:380–396.
3. He H, Yiu SC. Stem cell-based therapy for treating limbal stem cells deficiency: a review of different strategies. Saudi J Ophthalmol. 2014;28:188–194.
4. Li F, Zhao SZ. Mesenchymal stem cells: potential role in corneal wound repair and transplantation. World J Stem Cells. 2014;6:296–304.
5. Town M, Jean G, Cherqui S, et al. A novel gene encoding an integral membrane protein is mutated in nephropathic cystinosis. Nat Genet. 1998;18:319–324.
6. Kalatzis V, Cherqui S, Antignac C, Gasnier B. Cystinosin, the protein defective in cystinosis, is a H(þ)-driven lysosomal cystine transporter. EMBO J. 2001;20:5940–5949.
7. Schneider JA, Schulman JD. Cystinosis: a review. Metabolism. 1977;26:817–839.
8. Schneider JA, Katz B, Melles RB. Update on nephropathic cystinosis. Ped Nephrol. 1990;4:645–653.
9. Gahl WA, Thoene JG, Schneider JA. Cystinosis. N Engl J Med. 2002;347:111–121.
10. Kleta R, Kaskel F, Dohil R, et al. First NIH/Office of Rare Diseases Conference on Cystinosis: past, present, and future. Ped Nephrol. 2005;20:452–454.
11. Cherqui S, Sevin C, Hamard G, et al. Intralysosomal cystine accumulation in mice lacking cystinosin, the protein defective in cystinosis. Mol Cell Biol. 2002;22:7622–7632.
12. Katz B, Melles RB, Schneider JA. Corneal sensitivity in nephropathic cystinosis. Am J Ophthalmol. 1987;104:413–416.
13. Kalatzis V, Serratrice N, Hippert C, et al. The ocular anomalies in a cystinosis animal model mimic disease pathogenesis. Ped Res. 2007;62:156–162.
14. Simpson J, Nien CJ, Flynn K, Jester B, Cherqui S, Jester J. Quantitative in vivo and ex vivo confocal microscopy analysis of corneal cystine crystals in the Ctns knockout mouse. Mol Vis. 2011;17:2212–2220.
15. Gahl WA, Kuehl EM, Iwata F, Lindblad A, Kaiser-Kupfer MI. Corneal crystals in nephropathic cystinosis: natural history and treatment with cysteamine eyedrops. Mol Genet Metab. 2000;71:100–120.
16. Kaiser-Kupfer MI, Caruso RC, Minkler DS, Gahl WA. Long-term ocular manifestations in nephropathic cystinosis. Arch Ophthalmol. 1986;104:706–711.
17. Tsilou ET, Rubin BI, Reed GF, Iwata F, Gahl W, Kaiser-Kupfer MI. Age-related prevalence of anterior segment complications in patients with infantile nephropathic cystinosis. Cornea. 2002;21:173–176.
18. Simpson JL, Nien CJ, Flynn KJ, Jester JV. Evaluation of topical cysteamine therapy in the CTNS(-/-) knockout mouse using in vivo confocal microscopy. Mol Vis. 2011;17:2649–2654.
19. Yamamoto GK, Schulman JD, Schneider JA, Wong VG. Longterm ocular changes in cystinosis: observations in renal transplant recipients. J Pediatr Ophthalmol Strabismus. 1979;16:21–25.
20. Richler M, Milot J, Quigley M, O’Regan S. Ocular manifestations of nephropathic cystinosis. The French-Canadian experience in a genetically homogeneous population. Arch Ophthalmol. 1991;109:359–362.
21. Cantani A, Giardini O. Ciarnella Cantani A. Nephropathic cystinosis: ineffectiveness of cysteamine therapy for ocular changes. Am J Ophthalmol. 1983;95:713–714.
22. Dufier JL, Dhermy P, Gubler MC, Gagnadoux MF, Broyer M. Ocular changes in long-term evolution of infantile cystinosis. Ophthalmic Paediatr Genet. 1987;8:131–137.
23. Kaiser-Kupfer MI, Gazzo MA, Datiles MB, Caruso RC, Kuehl EM, Gahl WA. A randomized placebo-controlled trial of cysteamine eye drops in nephropathic cystinosis. Arch Ophthalmol. 1990;108:689–693.
24. Labbe A, Baudouin C, Deschenes G, et al. A new gel formulation of topical cysteamine for the treatment of corneal cystine crystals in cystinosis: the Cystadrops OCT-1 study. Mol Genet Metab. 2014;111:314–320.
25. Sel S, Schilling UM, Nass N, et al. Bone marrow cells and CD117-positive haematopoietic stem cells promote corneal wound healing. Acta Ophthalmol. 2012;90:e367–373.
26. Harrison F, Yeagy BA, Rocca CJ, Kohn DB, Salomon DR, Cherqui S. Hematopoietic stem cell gene therapy for the multisystemic lysosomal storage disorder cystinosis. Mol Ther. 2013;21:433–444.
27. Syres K, Harrison F, Tadlock M, et al. Successful treatment of the murine model of cystinosis using bone marrow cell transplantation. Blood. 2009;114:2542–2552.
28. Yeagy BA, Harrison F, Gubler MC, Koziol JA, Salomon DR, Cherqui S. Kidney preservation by bone marrow cell transplantation in hereditary nephropathy. Kidney Int. 2011; 79:1198–1206.
29. Naphade S, Sharma J, Gaide Chevronnay HP, et al. Brief reports: lysosomal cross-correction by hematopoietic stem cell-derived macrophages via tunneling nanotubes. Stem Cells. 2015;33:301–309.
30. Chen DK, Frizzi KE, Guernsey LS, Ladt K, Mizisin AP, Calcutt NA. Repeated monitoring of corneal nerves by confocal microscopy as an index of peripheral neuropathy in type-1 diabetic rodents and the effects of topical insulin. J Periph Nerv Syst. 2013;18:306–315.
31. Lively GD, Jiang B, Hedberg-Buenz A, et al. Genetic dependence of central corneal thickness among inbred strains of mice. Invest Ophthalmol Vis Sci. 2010;51:160–171.
32. Cherqui S. Is genetic rescue of cystinosis an achievable treatment goal? Nephrol Dial Transplant. 2014;29:522–528.
33. Shikari H, Amparo F, Saboo U, Dana R. Onset of ocular graftversus- host disease symptoms after allogeneic hematopoietic stem cell transplantation. Cornea. 2015;34:243–247.
34. Nakamura T, Ishikawa F, Sonoda KH, et al. Characterization and distribution of bone marrow-derived cells in mouse cornea. Invest Ophthalmol Vis Sci. 2005;46:497–503.
35. Shah S, Chatterjee A, Mathai M, et al. Relationship between corneal thickness and measured intraocular pressure in a general ophthalmology clinic. Ophthalmology. 1999;106: 2154–2160.
36. Wei W, Fan Z, Wang L, Li Z, Jiao W, Li Y. Correlation analysis between central corneal thickness and intraocular pressure in juveniles in Northern China: the Jinan city eye study. PLoS One. 2014;9:e104842.
37. Emre S, Kayikcioglu O, Ates H, et al. Corneal hysteresis, corneal resistance factor, and intraocular pressure measurement in patients with scleroderma using the reichert ocular response analyzer. Cornea. 2010;29:628–631.
38. Sonmez K, Ozcan PY. Angle-closure glaucoma in a patient with the nanophthalmos-ocular cystinosis-foveoschisis-pigmentary retinal dystrophy complex. BMC Ophthalmology. 2012;12:23.
39. Wan WL, Minckler DS, Rao NA. Pupillary-block glaucoma associated with childhood cystinosis. Am J Ophthalmol. 1986; 101:700–705.
40. Marzo L, Gousset K, Zurzolo C. Multifaceted roles of tunneling nanotubes in intercellular communication. Front Physiol. 2012;3:72.
41. Rustom A, Saffrich R, Markovic I, Walther P, Gerdes HH. Nanotubular highways for intercellular organelle transport. Science. 2004;303:1007–1010.
42. Chinnery HR, Pearlman E, McMenamin PG. Cutting edge: membrane nanotubes in vivo: a feature of MHC class IIþ cells in the mouse cornea. J Immunol. 2008;180:5779–5783.
43. Seyed-Razavi Y, Hickey MJ, Kuffova L, McMenamin PG, Chinnery HR. Membrane nanotubes in myeloid cells in the adult mouse cornea represent a novel mode of immune cell interaction. Immunol Cell Biol. 2013;91:89–95.
44. Brown K, Fidanboylu M, Wong W. Intercellular exchange of surface molecules and its physiological relevance. Arch Immunol Ther Exp (Warsz). 2010;58:263–272.
45. Iglesias DM, El-Kares R, Taranta A, et al. Stem cell microvesicles transfer cystinosin to human cystinotic cells and reduce cystine accumulation in vitro. PLoS One. 2012;7:e42840.
46. Thoene J, Goss T, Witcher M, et al. In vitro correction of disorders of lysosomal transport by microvesicles derived from baculovirus-infected Spodoptera cells. Mol Genet Metab. 2013;109:77–85.
47. Coulson-Thomas VJ, Caterson B, Kao WW. Transplantation of human umbilical mesenchymal stem cells cures the corneal defects of mucopolysaccharidosis VII mice. Stem Cells. 2013; 31:2116–2126.